Hospital Cross-Subsidization Is Entering a More Fragile Era
For decades, American health systems have balanced their books through a financial bargain that was never especially stable. Commercially insured surgical patients helped cover losses from Medicare, Medicaid, and uninsured care. Hospital outpatient revenue also helped absorb physician employment losses, while profitable specialty lines carried services that communities expected but rarely paid for adequately. That structure allowed large systems to expand, modernize, and become dominant employers in their regions.
The pressure on that model is now coming from multiple directions at once.
Recent CMS action on July 2 threatens two central supports of the arrangement: 340B Medicaid drug payments and Medicare’s site-of-service payments for remote ambulatory care. At the same time, policy advocates are pushing harder for commercial price controls and site-neutral payment. The combined effect is blunt. If hospitals can no longer depend on elevated commercial margins or facility-based add-ons to cover lower-margin services, the old cross-subsidy formula weakens quickly.
Where the Money Has Really Been Flowing
The economics of hospital cross-subsidization depend on several overlapping transfers inside the same enterprise. Commercial payers subsidize government programs. Hospital outpatient charges subsidize physician employment. High-margin service lines subsidize community missions. Hospital outpatient departments subsidize inpatient care. Each of those arrangements has been treated for years as an operational necessity rather than a strategic vulnerability.
Commercial insurance pays hospitals roughly 2.5 times Medicare rates on average for the same services. That spread has helped offset the lower reimbursements tied to Medicare and Medicaid, which now account for the majority of volume in many systems, as well as the cost of treating uninsured patients. As government payer mix grows and state initiatives move toward price caps, the commercial margin that props up the entire enterprise becomes harder to preserve.
Physician employment presents a second pressure point. Health systems have historically invested about $256,000 per employed physician annually to make up the gap between practice revenue and operating expense. In many cases, that loss was tolerated because it bought referral capture, market positioning, and coordination. Once hospital facility fees entered the equation, however, physician time became more valuable inside the health system than in independent practice. The result accelerated employment, but it also increased the hospital’s own financial burden.
High-acuity specialties remain the most visible margin generators. Oncology, cardiovascular care, orthopedics, and neurosciences often supply a disproportionate share of operating profit. They are also among the most resource-intensive areas in medicine, which makes the margin look larger than the economics underneath it may truly be. Behavioral health, obstetrics, primary care, and emergency care carry the opposite profile: central to community access, chronically underpaid, and often structurally lossmaking.
The Policy Squeeze Is Tightening from Both Sides
Two political currents now point in the same financial direction. Site-neutral payment policy asks a simple question: if a procedure costs the same in a hospital outpatient department and an ambulatory surgery center, why should Medicare pay more in the hospital setting? That logic threatens the facility-fee premium many systems rely on to support overhead, physician losses, and inpatient subsidy.
Franchise protection is also under attack. Certificate of Need laws, still present in some states, shield incumbents from competition. Those protections are increasingly contested, and the ACA-era limits on physician-owned hospitals face renewed scrutiny as well. More competition means less ability to preserve margins through geographic control alone.
Commercial price caps add another layer of restraint. Several states are either tying hospital commercial rates to Medicare, setting cost growth targets, or imposing global budgets. Each mechanism narrows the gap between commercial pricing and actual delivery cost. For systems that have long depended on that differential to finance mission-heavy but low-margin operations, the result is less room to maneuver and fewer ways to disguise inefficiency.
A hospital that cannot identify its real costs is already late.
Medicare Breakeven Requires Harder Choices Than Most Systems Have Made
The article argues that health systems need to stop treating Medicare losses as an unavoidable fact of life. Medicare payments were designed to cover the cost of caring for older adults, yet many hospital leaders have accepted chronic Medicare losses as if they were immutable. In practice, that mindset shifts the burden onto commercial payers and masks internal inefficiency.
Breaking even on Medicare, including Medicare Advantage, requires more than cost cutting at the margins. It demands a redesign of the operating model, elimination of services that are not sustainably staffed or sized, and a willingness to exit underperforming Medicare Advantage contracts or weak provider-sponsored plans. Systems must manage the delivered cost of DRGs and APCs with the same seriousness they bring to revenue capture.
The argument is especially forceful because Medicare Advantage now covers more than half of the Medicare program. That means the old distinction between traditional Medicare and managed Medicare is no longer enough to justify separate strategies. A health system that cannot compete on efficiency in either product will keep leaning on commercial rates until those rates are no longer available.
Ambulatory Growth and Physician Enterprise Rebuild the Balance Sheet
The shift toward ambulatory care is not optional; it is already reshaping where value is created. Systems that want to profit from ambulatory growth will need more than a new building or a branded outpatient campus. They will need redesigned workflows, tighter scheduling, better network performance on contracted rates, and operating discipline that matches the lower-cost setting.
Physician enterprise losses deserve the same scrutiny. They are among the largest drains on the hospital income statement, but they are not inevitable. More convenient scheduling, value-based payment upside, new joint ventures, and carefully structured partnerships can change the economics. In some cases, shrinking employment may be the right answer. The reflex to employ more physicians simply to preserve market share is becoming harder to defend when the subsidy itself is eroding.
Specialization Will Decide Which Systems Stay Viable
The future likely belongs to systems that make explicit choices about what they will do, where they will do it, and for whom they will do it. That may mean service-line partnerships with competitors, shared infrastructure, or consolidation of geographically proximate facilities inside a single enterprise. It may also mean referring out services that cannot be delivered safely or profitably.
Those are not small decisions. They challenge the long-held instinct that a health system should offer everything everywhere. Yet the economics no longer support that habit. In a world where commercial reimbursement is less generous, government payment is under pressure, and outpatient care migrates toward lower-cost settings, breadth without discipline becomes a liability.
The cross-subsidy model did important work for a long time. It financed infrastructure, supported mission-heavy care, and helped health systems absorb the uneven economics of American payment policy. Now the financing environment is changing faster than the model itself. Leaders who keep treating cross-subsidization as a permanent operating principle will find fewer levers to pull and fewer margins left to spend.